Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02811861 |
|---|---|
| Brief Title: | Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma (CLEAR) |
| First Submitted : | June 21, 2016 |
| First Submitted that Met QC Criteria : | June 21, 2016 |
| First Posted : | June 23, 2016 (Estimate) |
| Results First Submitted : | August 27, 2021 |
| Results First Submitted that Met QC Criteria : | August 27, 2021 |
| Results First Posted : | September 24, 2021 |
| Last Update Submitted that Met QC Criteria : | July 7, 2023 |
| Last Update Posted : | July 10, 2023 |